Swiss Life Funds (LUX) Equity Europe High Dividend EUR I Dis

Performance (in EUR)

Past performance is no indication of current or future performance. These performance data do not take account of the commissions and costs incurred on the issue and redemption of units.

Performance

1 month -2.65%
Current year 5.74%
3 years p.a. 11.92%
5 years p.a. n.a.
10 years p.a. n.a.
Since inception p.a. n.a.

Rolling performance in %

Key figures

YTD 1 year 3 years 5 years 10 years
Performance 5.74% 12.92% 40.23% n.a. n.a.
Maximum profit on monthly basis 7.04% 7.04% 7.04% n.a. n.a.
Maximum loss on monthly basis -2.65% -2.65% -4.61% n.a. n.a.
Max drawdown -5.43% -11.51% -11.83% n.a. n.a.
Volatility 11.45% 12.69% 11.09% n.a. n.a.
Sharpe ratio 1.96 0.77 0.81 n.a. n.a.
Maximum continuous profit in months 2 2 3 n.a. n.a.
Maximum continuous loss in months 1 1 1 n.a. n.a.
Positive months / profit duration in months 3 8 24 n.a. n.a.
Negative months / loss duration in months 1 5 13 n.a. n.a.

Master data

Fund name Swiss Life Funds (LUX) Equity Europe High Dividend EUR I Dis
Fund management company Swiss Life Asset Managers Luxembourg
Fund domicile Luxembourg
Inception date 05 July 2022
ISIN LU2477750645
Fund currency EUR
Appropriation of income distributing
Issuing commission
Ongoing charges under PRIIP KID as at 01 January 2026 0.79%
End of financial year 31 August
Paying agent
Fund volume as at 31 December 2025 116.87 Mio. EUR
Net asset value (NAV) as at 31 March 2026 152.29 EUR

Portfolio structure

Top holdings of fund volume (in %)

Novartis AG 6.25%
British American Tobacco 6.01%
Roche Hldg. Genußsch. 3.92%
TotalEnergies SE 3.68%
Allianz SE 3.66%
DHL Group (ex Deutsche Post World Net) 3.59%
Zurich Insurance Group AG 3.46%
Shell PLC 3.36%
Sanofi 3.05%
Imperial Brands PLC 2.69%

Asset allocation

Currency

Countries

Sectors